Browsing Tag
Dr Karen O’Hanlon
2 posts
Fridge-free vaccine milestone: Stablepharma locks Phase I SPVX02 data in thermostability push
Stablepharma has completed its first human trial for SPVX02, a fridge-free tetanus-diphtheria vaccine designed to work without cold-chain storage. With the data now locked, the company is preparing to scale its thermostable platform for global deployment.
Stablepharma’s fridge-free vaccine breakthrough: Dr Karen O’Hanlon explains the StablevaX journey
Find out how Stablepharma’s SPVX02 could redefine global vaccine logistics with fridge-free technology. Dr Karen O’Hanlon explains the science behind StablevaX™.